Regulatory Approvals

FDA approves ADHD drug with novel mechanism of action

By

Regulatory Approvals — FDA approves ADHD drug with novel mechanism of action  Новости GxP

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. July 29, 2026.

By

Related Post

Regulatory Approvals

TB FDA approves first generic rifapentine

Regulatory Approvals

FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening

Regulatory Approvals

FDA approves first OTC combo of Tylenol and Naproxen for pain relief

Financial News For All

Business Economy Finance

Commodities Price Update: Crude Oil $82.59, Brent $87.75, Copper $6.32, Coal $104.75 — Jul 29, 2026 8:00 AM EDT

Mergers & Acquisitions

EXCLUSIVE: Unilever agrees two-year worker protection after $65 billion McCormick merger, memo shows

Mergers & Acquisitions

LEONARDO IS EXPANDING IN THE US WITH THE ACQUISITION OF RAFT

Mergers & Acquisitions

CG Life embraces next-gen era in merger with AI-native agency The Considered+AI